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The polymeric glyco-linker controls the signal
outputs for plasmonic gold nanorod biosensors
due to biocorona formation†
Alessia Pancaro, a,b Michal Szymonik, a Panagiotis G. Georgiou, c
Alexander N. Baker,c Marc Walker,d Peter Adriaensens, e Jelle Hendrix, b
Matthew I. Gibson *c,f and Inge Nelissen *a
Gold nanorods (GNRs) are a promising platform for nanoplasmonic biosensing. The localised surface
plasmon resonance (LSPR) peak of GNRs is located in the near-infrared optical window and is sensitive to
local binding events, enabling label-free detection of biomarkers in complex biological fluids. A key chal-
lenge in the development of such sensors is achieving target affinity and selectivity, while both minimizing
non-specific binding and maintaining colloidal stability. Herein, we reveal how GNRs decorated with
galactosamine-terminated polymer ligands display significantly different binding responses in buffer com-
pared to serum, due to biocorona formation, and how biocorona displacement due to lectin binding plays
a key role in their optical responses. GNRs were coated with either poly(N-(2-hydroxypropyl)methacryla-
mide) (PHPMA) or poly(N-hydroxyethyl acrylamide) (PHEA) prepared via reversible addition–fragmentation
chain-transfer (RAFT) polymerisation and end-functionalised with galactosamine (Gal) as the lectin-tar-
geting unit. In buffer Gal-PHEA-coated GNRs aggregated upon soybean agglutinin (SBA) addition,
whereas Gal-PHPMA-coated GNRs exhibited a red-shift of the LSPR spectrum without aggregation. In
contrast, when incubated in serum Gal-PHPMA-coated nanorods showed no binding response, while
Gal-PHEA GNRs exhibited a dose-dependent blue-shift of the LSPR peak, which is the opposite direction
(red-shift) to what was observed in buffer. This differential behaviour was attributed to biocorona for-
mation onto both polymer-coated GNRs, shown by differential centrifugal sedimentation and nano-
particle tracking analysis. Upon addition of SBA to the Gal-PHEA coated nanorods, signal was generated
due to displacement of weakly-bound biocorona components by lectin binding. However, in the case of
Gal-PHPMA which had a thicker corona, attributed to lower polymer grafting densities, addition of SBA
did not lead to biocorona displacement and there was no signal output. These results show that plasmo-
nic optical responses in complex biological media can be significantly affected by biocorona formation,
and that biocorona formation itself does not prevent sensing so long as its exact nature (e.g. ‘hard versus
soft’) is tuned.
Introduction
Spherical gold nanoparticles (GNPs) are one of the most
widely studied nanomaterials. Their established and versatile
synthetic methods, biocompatibility, ease of surface functiona-
lisation and unique optical properties1,2 have facilitated a wide
range of applications in diagnostics, therapeutics and drug
delivery.3–6 The optical properties of GNPs are dominated by
the phenomenon of localised surface plasmon resonance
(LSPR), a collective oscillation of electrons in resonance with
incident light, strongly localised to the GNPs surface.7,8 The
wavelength of this oscillation is dependent on the size of the
particle and the refractive index of the surrounding medium.
This property has been exploited to produce biosensor devices,
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as the binding of biomolecules to the GNP’s surface leads to
changes in the LSPR peak, which are easily measured.9,10 Many
colorimetric assays, for chemical and biological sensing appli-
cations, have been developed based on, for example, aggrega-
tion, etching, growth and nanozymes.11 For example, a colori-
metric assay using glyco-GNPs have been reported for the detec-
tion of lectins, cholera toxin and influenza viruses.12–14
Changes in the nanoparticle shape affect a GNR’s plasmo-
nic properties, which can be advantageous for biosensing
applications. The anisotropy of gold nanorods (GNRs) leads to
a splitting of the optical absorption bands into two separate
LSPR peaks corresponding to resonances along the short and
long axes of the rod, termed the transverse and longitudinal
bands respectively. The longitudinal band is typically more
sensitive to local refractive index changes than the transverse
peak.15 Importantly, and in contrast to spherical GNPs, the
absorbance maximum of this peak is dependent on the rod
aspect ratio and can be fine-tuned from visible to near-infrared
(λ ∼ 600 to >1300 nm), where biological tissues exhibit the
highest optical transparency.10,16–18 This allows measurement
directly in complex biological fluids such as blood, enabling a
broad range of in vitro and in vivo applications.19 Therefore,
GNR-based LSPR sensors represent an important advancement
for rapid, simple, label-free, and sensitive detection of low
target molecule concentrations.20–23 For example, lactose-func-
tionalised GNRs have been fabricated as efficient biosensors to
detect the cancer biomarker Galectin-1 at concentrations
below 10−13 M.24 Lipid-capped GNRs have been used for the
label-free detection of a lipophilic drug in aqueous solution
and a lipopeptide in serum.25 GNRs can also provide signal
enhancement in chip-based SPR detection. For example, Law
et al. have shown a 40-fold sensitivity enhancement for the
detection of tumour necrosis factor alpha (TNF-α) when using
antibody-conjugated GNRs as a plasmonic coupling partner.26
Compared to other plasmonic nanostructures, gold nanorods
show high plasmonic surface sensitivity due to their high
aspect ratio.27
To enable LSPR-based biosensing, the nanoparticles must
be decorated with recognition units tethered to the surface by
a ligand. In this work, we focused on the detection of lectins,
which are glycan-binding proteins that play a key role in many
biological processes, including cell–cell adhesion, cell reco-
gnition, cell differentiation, and infection by pathogens.28–30
Lectins interact only weakly (millimolar Kd values) with indi-
vidual monosaccharides, however multivalent interactions
result in Kd values in the nanomolar range towards their
glycan targets.31–35 The multivalent presentation of the same
glycan compensates for the low lectin–monosaccharide
affinity, leading to a non-linear increase in binding affinity,
termed the “cluster glycoside effect”.32,36
A broad range of surface ligands including peptides,37 poly-
mers,38 and cationic thiolated ligands39 among others,40 have
been used to stabilize nanoparticles and anchor functional
groups. Using polymeric ligands, Gibson and co-workers have
demonstrated the importance of tuning the polymer length to
achieve the crucial balance between stability and aggregation
of glyco-nanoparticles upon lectin binding.41–44 In addition,
ligands play a key role in controlling particle surface properties,
such as charge and chemical reactivity, which drive a particle’s
interactions with bio(macro)molecules. Exposure of nano-
particles to complex biological media leads to the formation of
a biomolecular corona, termed a “biocorona”.45–49 The biocoro-
nas initially consist of the most abundant and fast-diffusing
molecules in solution, before being partially replaced over time
by proteins that have a higher affinity for the nanoparticle
surface. These higher affinity proteins can act to mask the
ligands displayed on the nanoparticles, an hence interfere with
their recognition capability.50,51 For example, transferrin coated
nanoparticles have been shown to loose their targetting capacity
due to protein corona formation.52 Understanding the dynamic
exchange rates between bound and unbound proteins on nano-
particles in biological systems is vital for the design of new
nanoparticle-based biosensors capable of detecting target mole-
cules directly in the physiological environment.53–56
Herein, we study the sensing performance of GNRs coated
with galactosamine-modified polymeric linkers for the detec-
tion of the lectin soybean agglutinin (SBA), used as a model
analyte. We observe how the structure of surface tethered gly-
copolymers controlled the magnitude and reversibility of
serum–biomolecule binding to the nanoparticles and explore
the impact of this on biosensing in serum, compared to
simple buffers. It is found that careful selection of the poly-
meric linker promotes the formation of a reversible biocorona,
which can be displaced upon lectin binding, generating signal.
This shows that biocorona formation in complex media does
not fundamentally prevent gold nanorod biosensing and that
macromolecular engineering of the polymer tethers can be
used to optimise device performance.
Experimental
Materials
All reagents were used as supplied, unless otherwise stated.
Citrate-stabilised gold nanorods (GNRs) of 10 nm width and
38 nm length (λmax = 780 nm) were purchased from Nanopartz.
Human serum (H6914), D-(+)-galactosamine hydrochloride
(99%), HEPES buffer, NaCl, CaCl2, triethylamine (>99%), 2-
(dodecylthiocarbonothioylthio)-2-methylpropionic acid penta-
fluorophenyl ester (98%, PFP-DMP), and monomers N-(2-hydro-
xypropyl)methacrylamide (99%, HPMA) and N-hydroxyethyl
acrylamide (97%, HEA) were all purchased from Sigma-Aldrich.
MnCl2 was purchased from VWR. Soybean agglutinin (SBA)
lectin was obtained from Vector Laboratories. Photo-polymeris-
ation reactions were conducted using a blue LED strip light
(3 meters with 180 LEDs, λ = 460–465 nm). All experiments were
conducted using Milli-Q grade water (resistivity of 18.2 mΩ cm
at 25 °C, 4 ppb total organic carbon).
Methods
Polymer synthesis and glycan modification. The synthesis
and characterisation of PFP-PHPMA (pentafluorophenyl ester-
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poly(N-(2-hydroxypropyl) methacrylamide)) and PFP-PHEA
(pentafluorophenyl ester-poly(N-hydroxyethyl acrylamide))
with a range of degrees of polymerisations (40, 50, 55, 68 for
PFP-PHPMA and 26, 35, 50, 60 for PFP-PHEA), as well as end-
group modification using galactosamine (Gal) were performed
according to previously reported experimental protocols (see
ESI† for detailed synthetic procedure).57
(Glyco)polymer conjugation onto gold nanorods surface.
Approximately 2 mg of each (glyco)polymer was dissolved in
200 µL of water and mixed by pipetting with 800 µL of GNR
suspension at 5 OD. After a 30 min incubation at room temp-
erature in the dark, the particles were sonicated for 1 min
using an ultrasonic bath at 40 kHz (Branson CPX1800H), cen-
trifuged at 12 000g and 20 °C for 10 min, and the supernatant
removed. This was followed by 3 cycles of re-suspension in
1 mL water, centrifugation and decanting. A Sigma 3-30KS cen-
trifuge was used with 1.5 mL volume tubes for all preparative
centrifugation. The particles were finally resuspended in 1 mL
water (OD = 4) and stored in polypropylene graduated tubes at
4 °C until use.
Saline stability-induced aggregation studies. A solution of 1
M NaCl was serially diluted down to 0.031 M in clear, flat-bot-
tomed 384-well NUNC plates and used for all optical measure-
ments. 3 µL of citrate-GNRs and conjugated GNRs were added
to each well, mixed and incubated at room temperature for
30 min, and then an absorbance spectrum was recorded from
400 nm to 1000 nm with 1 nm resolution.
Lectin binding studies by absorbance. A stock solution of
1 mg mL−1 SBA was prepared in 10 mM HEPES buffer (pH 7.5)
containing 50 mM NaCl, 0.1 mM CaCl2 and 0.01 mM MnCl2.
Functionalised GNRs (3 µL, yielding ∼0.3 final OD) were added
to a series of different SBA concentrations (10–100 µg mL−1) in
HEPES buffer for a final volume of 40 µL. The plate was gently
agitated at room temperature for 30 min, and then absorbance
spectra were recorded every 30 min over 2 hours from 400 to
999 nm with 1 nm interval using a Biotek Synergy HT micro-
plate reader.
For the assay carried out in serum, lyophilised SBA was dis-
solved in human serum at 1 mg mL−1 and diluted in serum
(10–100) µg mL−1. A CLARIOstar Plus plate reader (BMG
Labtech) was used to record spectra every 5 min, with 30
seconds of plate shaking prior to each measurement.
(Glyco)polymer-coated GNRs studies in serum. (Gal)-PHEA35
coated GNRs (300 µL) were added to 1.5 mL of human serum
in a 2 mL Eppendorf Protein LoBind tube and incubated at
room temperature for 2 hours on a shaker at 40 rpm to allow
formation of a biocorona on the particles’ surface. The GNRs
suspension was centrifuged at 12 000g for 10 min at 20 °C, the
supernatant was removed and the pellet washed three times by
pipetting in 1 mL of 10 mM HEPES buffer. The particles were
finally resuspended in 300 µL HEPES buffer and 40 µL
volumes transferred to the wells of a 384-well plate. UV-Vis
spectra were recorded every 5 min. After 1 hour, 4 µL of 1 mg
mL−1 SBA was injected to a final concentration of 100 µg mL−1
and the response monitored for a further 3 hours. To quantify
the thickness of the biocorona, Gal-PHPMA40 and (Gal)-
PHEA35 coated GNRs were analysed directly in serum (without
washing) using differential centrifugal sedimentation (DCS) as
described below.
Characterisation techniques
NMR spectroscopy. Proton (1H-NMR) and fluorine
(19F-NMR) nuclear magnetic resonance spectra were recorded
at 300 MHz or 400 MHz on a Bruker DPX-300 or DPX-400
spectrometer respectively, with methanol-d4 as the solvent.
Chemical shifts of protons are reported as δ in parts per
million (ppm). Alternatively, NMR spectra were recorded at
room temperature on a Varian/Agilent Inova 400 MHz spectro-
meter using a 5 mm four-nucleus pulsed field gradient (PFG)
probe. For 1H-NMR, the chemical shift scale (δ) in ppm was
calibrated relative to methanol-d4 (3.31 ppm), while CFCl3
(0 ppm) was used for 19F-NMR. For 1H-NMR (19F-NMR), free
induction decays were collected with a 90° pulse of 6.8 (8.0) μs,
a spectral width of 6.6 (21) kHz, an acquisition time of 3.5
(0.5) s, a preparation delay of 12 (1) s and 32 (400) accumu-
lations (scans). A line-broadening factor of 0.3 Hz (1H-spectra)
or 5 Hz (19F-spectra) was applied before Fourier transformation
to the frequency domain.
FT-IR spectroscopy. Fourier Transformed-Infrared (FT-IR)
spectroscopy measurements were carried out in the range of
650 to 4000 cm−1 using a Cary 630 FT-IR spectrometer
(Agilent) or Nicolet iS10 spectrometer (Thermo Fisher
Scientific) in the range of 4000 to 400 cm−1.
Size exclusion chromatography (SEC). SEC analysis was per-
formed on an Infinity II MDS instrument (Agilent) equipped
with differential refractive index (DRI), viscometry (VS), dual
angle light scatter (LS) and variable wavelength UV detectors.
The system was equipped with 2 × PLgel Mixed D columns
(300 × 7.5 mm) and a PLgel 5 µm guard column. The mobile
phase used was dimethylformamide (DMF) HPLC grade con-
taining 5 mM NH4BF4 at 50 °C at flow rate of 1.0 mL min
−1.
Poly(methyl methacrylate) (PMMA) standards (Agilent
EasyVials) were used for calibration between 555–955 000 g
mol−1. Analyte samples were filtered through a nylon mem-
brane with 0.22 μm pore size before injection. Number average
molecular weights (Mn), weight average molecular weights
(Mw) and dispersities (ĐM = Mw/Mn) were determined by con-
ventional calibration using Agilent SEC software.
UV-Visible spectroscopy. UV-Vis absorption spectra were
acquired at room temperature (25 °C) on a CLARIOstar Plus
spectrophotometer. All absorbance spectra were recorded
between λ = 400–1000 nm with 1 nm resolution and 30
seconds of plate shaking at 100 RPM applied before each
measurement. Results were smoothed using a Savitzky–Golay
filter (order 4, window width 31). Peak maxima were deter-
mined from the zero crossings of the derivative of the
smoothed data. All measurements were performed with at
least two replicates (n ≥ 2).
Differential centrifugal sedimentation (DCS) was performed
to assess binding of glycopolymers, serum molecules and SBA
on the GNR surface by measuring the particles’ size distri-
bution. For this a CPS DC24000 disc centrifuge was used with
Nanoscale Paper
























































































a 8–24% (w/w) sucrose gradient and a rotation speed of 24 000
RPM. For measurements in serum, a fresh sucrose gradient
was prepared for each measurement. Before each run, polyvi-
nyl chloride latex beads (239 nm) with narrow size distribution
are used as calibration standard to ensure accuracy of the
measurements. All the measurements were performed with at
least two replicates (n ≥ 2). As the settling of particles is shape-
dependent, for GNRs a ‘non-sphericity factor’ (NSF) of 2.85
was applied in the CPS software. The binding of biomolecules
onto the GNRs’ surface increases the particles’ size, but lowers
their overall density. The CPS analysis assumes a constant par-
ticle density, so over-estimating the particle density means an
under-estimate of the particle size.58,59 For this reason, the
binding of polymers or biomolecules to the GNRs results in an
apparent decrease in the particle size reported by CPS. A core–
shell mathematical model was used to analyse the coating
thickness of the GNRs as previously described.60,61
Nanoparticle tracking analysis (NTA) was performed to
measure GNR sizes before and after functionalisation using a
NanoSight NS500 instrument in scatter mode with a laser
output of 75 mW at 532 nm (green) and sCMOS camera
(camera level set at 15). All the samples were analysed in dupli-
cate at 25 °C and 3 videos of 60 seconds were recorded (1499
frames with 25 frames per second) for each sample. The
number of particles/frame ranged from 30 to 90 for the GNR
samples, and none were detected in the buffer control. The
samples were diluted to 108–109 particles per mL in MilliQ
water, or 0.22 µm (Millex-GV) filtered HEPES buffer for serum-
incubated samples that were washed in buffer. For calibration,
100 nm polystyrene (PS) microspheres were used. The mode
was derived from a particle number concentration-based size
distribution using the NTA software version 3.0.
ζ-Potential was measured on a ZetaView-Twin instrument
(Particle Metrix). Alumina zeta potential standard was used
and all samples were measured in 11 positions at 22 °C in
triplicate. Zeta potential was calculated from the corres-
ponding electrophoretic mobilities (μE) by using Henry’s cor-
rection of the Smoluchowski equation (μE = 4πε0εrζ(1 + κr)/
6πμ), where ε0 is the dielectric permittivity of the vacuum, εr is
the relative permittivity of the liquid, ζ is the zeta potential, κ
is the Debye length, r is the particle radius and μ is the
mobility.
Dynamic light scattering (DLS) was measured on a
Zetasizer ZS (Malvern Panalytical). Measurements were carried
out using a 4 mW He–Ne 633 nm laser module operating at
25 °C at an angle of 173° (back scattering), and results were
analysed using Malvern DTS 7.03 software. All determinations
were repeated in duplicate with at least 5 measurements
recorded for each run.
Transmission electron microscopy. Dry-state stained TEM
imaging was performed on a JEOL JEM-2100Plus microscope
operating at an acceleration voltage of 200 kV. All dry-state
samples were diluted with deionised water and then deposited
onto formvar-coated copper grids.
X-ray photoelectron spectroscopy (XPS). The samples were
attached to electrically-conductive carbon tape, mounted onto
a sample bar and loaded into a Kratos Axis Ultra DLD spectro-
meter which possesses a base pressure below 1 × 10−10 mbar.
XPS measurements were performed in the main analysis
chamber, with the sample being illuminated using a mono-
chromated Al Kα X-ray source. The measurements were con-
ducted at room temperature and at a take-off angle of 90° with
respect to the surface parallel. The core level spectra were
recorded using a pass energy of 20 eV (resolution approx. 0.4
eV), from an analysis area of 300 μm × 700 μm. The spectro-
meter work function and binding energy scale were first cali-
brated using the Fermi edge and 3d5/2 peak recorded from a
polycrystalline Ag sample. In order to prevent surface charging,
the surface was flooded with a beam of low energy electrons
throughout the experiment and this necessitated recalibration
of the binding energy scale. To achieve this, the C–C/C–H com-
ponent of the C 1s spectrum was referenced to 285.0 eV. The
data were analysed in the CasaXPS package, using Shirley back-
grounds and mixed Gaussian–Lorentzian (Voigt) lineshapes.
For compositional analysis, the analyser transmission function
has been determined using clean metallic foils to determine
the detection efficiency across the full binding energy range.
Results and discussion
Polymer synthesis
Two water soluble, non-ionic polymers, poly(N-(2-hydroxypro-
pyl) methacrylamide) (PHPMA) and poly(N-hydroxyethyl acryl-
amide) (PHEA), were synthesised by photo-initiated RAFT poly-
merisation to maximise end-group fidelity. These polymers
have previously been used to functionalise spherical gold
nanoparticles, where subtle structural differences were found
to produce large changes in grafting density and responses to
analyte binding.57 Each polymer was prepared with four
different degrees of polymerisation (DP = 40, 50, 55, 68 for
PHPMA and DP = 26, 35, 50, 60 for PHEA) by tuning the feed
ratio. Polymers were characterised using 1H-NMR and SEC
(Fig. S1 and S2, ESI†). Narrow monomodal molecular weight
distributions were observed with low dispersity values (ĐM ≤
1.3) in all cases indicating a controlled photo-polymerisation
(Table 1). DP was also assessed by 1H NMR end-group analysis
in methanol-d4 showing Mn values lower than that found from
SEC, as has been previously reported.57 Polymer DP (in sub-
script) referred to from here is from 1H NMR. Retention of the
pentafluoro phenyl (PFP) end-group during polymerisation
was confirmed via 19F NMR (Fig. S3, ESI†) and FT-IR analysis.
Galactosamine was installed at the end-groups for both PHEA/
PHPMA homopolymers displacement of the PFP end-group at
the α-terminus,62 and confirmed by 19F-NMR and FT-IR ana-
lysis before and after modification (Fig. S3 and S4, ESI†).
Conjugation of glycopolymers onto gold nanorods
Citrate-stabilised GNRs were mixed with thiocarbonylthio-ter-
minated polymers (PHPMAn and PHEAn) or thiocarbonylthio-
terminated glycopolymers (Gal-PHPMAn and Gal-PHEAn,
Scheme 1) of various lengths (n) to produce a library of (glyco)
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polymer-coated GNRs (termed (Gal)-PHPMA GNRs and (Gal)-
PHEA GNRs). Excess of polymer was removed by multiple cen-
trifugation and resuspension cycles.
The physico-chemical properties for the glycopolymer-
coated GNRs and unmodified GNRs were analysed by UV-Vis,
ζ-potential, XPS, TEM, DLS, DCS and NTA (Fig. 1, Tables S1
and S2 and Fig. S5–S7, ESI†). All functionalised nanorods were
colloidally stable in aqueous solution apart from those conju-
gated with the shortest PHEA26 (or Gal-PHEA26) which led to
macroscopic precipitation (data not shown) and were not
taken further in this study. UV-Vis spectroscopy revealed a red-
shift of the longitudinal LSPR band (Fig. 1A) for the glycopoly-
mer coated GNRs, while DLS (Fig. 1B) and ζ-potential
(Table S1, ESI†) confirmed the successful attachment of the
glycopolymers to the particle surface. An example TEM is
shown in Fig. 1D showing the nanorod dimensions were
retained (i.e. no ripening of particles) during coating.
Differential centrifugal sedimentation (DCS) and nanoparticle
tracking analysis (NTA) also supported an increase in particle
size following polymer addition (see Table S1, ESI†).
To further confirm the presence of glycopolymers on the
surface of the GNRs, X-ray photoelectron spectroscopy (XPS)
analysis was performed on Gal-PHPMA40 and Gal-PHEA35
coated GNRs (Fig. 1C and Fig. S5 and S6, ESI†). The presence
of N 1s peaks, which are not present on the naked particles
(Fig. S7, ESI†) or found commonly in background contami-
nants, confirmed successful binding of the polymers onto the
particle surface (Table S2, ESI†). The ratio of N 1s : Au 4f peak
areas was higher for PHEA35-GNRs versus PHPMA40, indicating
a higher surface grafting density for the PHEA polymer.57
Note, the impact of grafting density is discussed later in this
article.
One prerequisite for any biomedical application of nano-
particles is their colloidal stability under physiological con-
ditions, and in particular due to saline which is present at
∼0.150 M (NaCl). We tested the stability of the conjugated gold
nanorod suspensions by titrating NaCl and using UV-Vis to
monitor aggregation. Citrate-GNRs aggregated above 0.125 M
NaCl, while all Gal-PHPMA GNRs (DP 40, 50, 55, 68) and Gal-
PHEA GNRs (DP 35, 50, 60) remained as stable dispersions up
to 1 M NaCl (Fig. S8, ESI†). The increased colloidal stability is
essential for sensing applications to avoid false-positive read-
outs and also provides additional evidence for the polymer
coating providing steric stabilisation.
Lectin binding studies in buffer
The plant lectin soybean agglutin (SBA) was employed as a
model system to study the lectin binding behaviour of various
glycopolymer-coated GNRs. SBA has high affinity for
N-acetylgalactosamine (GalNAc).63–65 When conjugated to the
polymers via an amide bond, galactosamine acts as a struc-
tural mimic of GalNAc.57 The particles were incubated with
SBA concentrations between 0 and 100 µg mL−1 in 10 mM
HEPES buffer and UV-Vis spectra recorded to observe changes
in the LSPR peaks. Wheat germ agglutinin (WGA) which exhi-















PHPMA40 40 100 6300 9600 1.17
PHPMA50 60 83 7700 11 300 1.22
PHPMA55 80 69 8400 12 500 1.19
PHPMA68 100 68 10 300 15 500 1.25
PHEA26 120 22 3500 8200 1.13
PHEA35 140 25 4600 9800 1.12
PHEA50 160 31 6300 14 500 1.13
PHEA60 180 33 7400 16 500 1.11
a Polymer names are determined according to the average degree of
polymerisation (DP) determined by 1H-NMR end-group analysis in
methanol-d4.
b [M] : [CTA] indicates the ratio between monomers (M)
and the chain transfer agents (CTA). cMonomer conversion (%) calcu-
lated by comparing the integration values of the monomer signals
with those of the corresponding signals of the polymer. d Mn, NMR was
calculated by end-group analysis by comparing the integrations of the
–CH3 signals (δ 0.92 ppm) of dodecyl end-group with those of the
corresponding signals of the polymer backbone. e Mn and ĐM values
calculated from PMMA standards using 5 mM NH4BF4 in DMF as the
eluent.
Scheme 1 Schematic of end-group modification of PFP-PHPMA (left)
and PFP-PHEA (right) telechelic homopolymers of different chain
lengths (n) using galactosamine, followed by functionalisation of citrate-
stabilised gold nanorods. Note, RAFT agent cleavage can occur during
functionalisation depending on excess used, but does not affect GNR
immobilisation.
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bits low affinity towards GalNAc,66 and particles with non-gly-
cosylated polymer were used as negative controls.
Despite only minor structural differences, the behaviour for
the two polymers upon analyte addition was markedly
different. Addition of SBA to Gal-PHEA GNRs (DP 35, 50, 60)
led to cross-linking and aggregation with shorter linker
lengths as seen by broadening of the LSPR peak and a
decrease in the overall absorbance (Fig. S9/S10, ESI†)67 – this
was also visible to the naked eye. No change in the spectrum
was observed with WGA (wheat germ agglutinin, which has no
affinity to GalNAc) or using non-glycosylated polymers
(Fig. S11/S12, ESI†). The same assay carried out with Gal-
PHPMA GNRs (DP 40, 50, 55, 68) produced no aggregation, but
instead an SBA concentration-dependent red-shift of the LSPR
peak which is attributed to the local refractive index changes
at the surface due to the binding interaction. Moreover,
increasing the linker length led to a decrease in the assay sen-
sitivity, as can be seen by the smaller LSPR peak shift (Fig. 2),
which would be consistent with increasing distance of the
binding event from the rod surface.68,69 Again, negative con-
Fig. 1 Glyconanoparticle characterisation. (A) Representative example of UV-Vis absorption spectra of GNRs coated with Gal-PHPMA and Gal-
PHEA of different lengths. Inset: zoomed view on the LSPR peak bands; (B) intensity-weighted DLS size distributions of Gal-PHEA35 GNRs compared
to pristine GNRs; (C) XPS C 1s characterisation of Gal-PHEA35 GNRs and (D) representative dry-state TEM image of Gal-PHEA35 GNRs.
Fig. 2 LSPR peak shift of Gal-PHPMA GNRs as a function of SBA con-
centration in buffer. Y-Axis shows the LSPR wavelength red-shift as
determined by UV-Vis spectroscopy after 2 hours of incubation.
Different PHPMA polymer lengths (DP = 40, 50, 55, 68) were compared.
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trols of WGA and non-glycosylated particles showed no
changes, as would be expected (Fig. S12, ESI†).
GNRs incubated with 100 µg mL−1 SBA were further studied
by DLS. For Gal-PHEA35 GNR there was clear aggregation in
agreement with the UV-Vis data (Fig. S13†) but there was no
aggregation for Gal-PHPMA40 GNR, although a small size
increase was seen. The different responses can be attributed to
the PHPMA ligands having lower grafting densities (and hence
fewer glycans) on the rod surface (as shown by XPS, above)
compared to PHEA, and provides further evidence that an
absence of aggregation does not always indicate an absence of
binding between different multivalent systems.57 Together,
this data shows that by carefully tuning the polymer tether, the
outcome of plasmonic bioassays towards either aggregation or
LSPR shifts can be fine-tuned, which is a valuable tool in the
design of nanoparticle biosensors.
Lectin binding studies in serum
The ability to use glycosylated PHPMA coated GNRs to target
lectins, but without any unwanted aggregation could be
appealing for in vivo or ex vivo biosensing, where aggregation
is undesirable. However, the behaviour predicted from buffer
(above) ignores the contribution and impact of other compet-
ing bio(macro)molecules which are present in many ‘real’
samples such as liquid biopsies. For this reason we evaluated
SBA binding towards Gal-PHPMA GNRs and Gal-PHEA GNRs
in serum. The stability of nanoparticles in such a complex
environment is generally considered to be provided by the for-
mation of the biomolecular corona.60
We monitored the LSPR peak following the addition of
glyco-GNRs to a dilution series of SBA in serum. The Gal-
PHPMA GNRs (DP 40, 50, 55, 68) showed no LSPR shift in the
concentration range tested (Fig. 3A and C and control trials
S14A/B†), in contrast to the strong LSPR shift observed in
buffer alone. In comparison, Gal-PHEA nanorods showed
dose-dependent LSPR shifts in serum plus SBA (Fig. 3B),
which is the opposite to what is seen for PHPMA. While aggre-
gation normally leads to a broadening of the LSPR peak, here
the shape of the LSPR peak of Gal-PHEA GNRs in serum did
not change significantly (Fig. 3D) and hence aggregation can
be excluded. This is in contrast to the aggregative behaviour
observed for the same assay performed in buffer, and confirms
Fig. 3 Response of nanoparticles to lectin in serum. LSPR peak shift of Gal-PHPMA GNRs (A) and Gal-PHEA GNRs (B) in serum as a function of SBA
concentration and measured after 2 hours of incubation. LSPR wavelength peak shift is expressed relative to the peak position at the start of the
injection (N = 3, mean ± SD). Representative UV-Vis spectra of Gal-PHPMA40 (C) and Gal-PHEA35 (D) coated GNRs in serum at time zero and 2 hours
after addition of 100 µg mL−1 SBA are shown.
Nanoscale Paper
























































































that initial screening in buffer is not be a reliable strategy for
identification of the best-performing surface modifications for
biosensing in blood/serum samples.
The response of Gal-PHEA35 GNR to SBA in serum was
found to be reproducible between batches of GNRs and
polymer (Fig. 4A) confirming this conflicting behaviour (com-
pared to what is seen in buffer alone) was a real effect. We also
assayed the response kinetics of Gal-PHEA35 GNR over 5 hours
using different SBA concentrations (Fig. 4B). In further control
experiments, PHEA GNRs without glycan modification exhibi-
ted excellent stability and minimal response to SBA injection
(Fig. S14C†), while Gal-PHEA GNRs showed no response upon
addition of WGA (Fig. S14D†), confirming the selective SBA
recognition of Gal-PHEA GNRs in complex serum conditions.
Impact of serum proteins on sensing performance
From the above studies, the most significant observation was
that in the case of Gal-PHEA GNRs in serum, the LSPR peak
wavelength decreases upon SBA addition, consistent with overall
loss of mass from the particle surface, rather than a net mass
gain due to lectin binding, which would have been expected if a
lectin was being captured by the rods in buffer. Secondly, the
PHPMA coated GNRs showed no response to SBA in serum
despite showing LSPR shifts in buffer. To explore the biocorona
formation and the impact this had during SBA biosensing, we
used differential centrifugal sedimentation (DCS). To estimate
the biocorona thickness from the DCS data we used the core–
shell model of Monopoli et al.60 where particles are treated as a
high-density metallic core with a lower-density shell of bio-
molecules. If the size and density of the core nanoparticle are
known and the density of the corona can be estimated, then the
shell thickness can be calculated from the shift in particle mobi-
lity before and after corona formation.
We observed an increase in coating thickness upon incu-
bation in serum for both Gal-PHPMA40 and Gal-PHEA35 GNRs
(Table 2 and Fig. S15 and S16†). The corona thickness was
higher for Gal-PHPMA40 rods (3.3 ± 0.2 nm) as compared to
Gal-PHEA35 GNRs (2.2 ± 0.2 nm). Upon addition of SBA to Gal-
PHPMA40 GNRs there was no change in the thickness of the
corona. However, in the case of Gal-PHEA35 there was actually
a decrease in total corona thickness following addition of SBA,
suggesting that the underlying mechanism for the Gal-PHEA
GNRs response in media could be due to a coronal displace-
ment mechanism, which does not occur for Gal-PHPMA
GNRs. Coronal displacement has been exploited by Rotello
et al.70,71 whereby a fluorescence polymer non-specifically
bound to gold particle surfaces is displaced to generate signal.
Fig. 5 proposes a mechanism for the sensing seen here,
whereby in the case of Gal-PHEA with a relatively thin corona,
addition of SBA leads to binding and displacement of weakly-
bound biocorona components, leading to the red shift (shorter
wavelength) of the LSPR. It is known that the behaviour of nano-
Fig. 4 SBA (100 µg mL−1) binding to Gal-PHEA35 coated GNRs in serum. (A) LSPR peak shift Gal-PHEA35 GNRs with 100 µg mL
−1 SBA in serum over
time (N = 4). The shaded range represents the standard deviation of the data. (B) Evolution of LSPR peak wavelength location over time (5 hours)
after addition of Gal-PHEA35 GNRs to serum containing different SBA concentrations.






PHEA35 GNRs Buffer 19.7 ± 0.1 1.5 ± 0.1
Serum 18.7 ± 0.1 2.2 ± 0.2
Serum + SBA 18.1 ± 0.1 2.8 ± 0.2
Gal-PHEA35 GNRs Buffer 19.7 ± 0.1 1.5 ± 0.1
Serum 18.7 ± 0.1 2.2 ± 0.2
Serum + SBA 19.5 ± 0.1 1.6 ± 0.1
PHPMA40 GNRs Buffer 19.7 ± 0.2 1.5 ± 0.1
Serum 17.6 ± 0.1 3.3 ± 0.2
Serum + SBA 17.5 ± 0.2 3.4 ± 0.2
Gal-PHPMA40 GNRs Buffer 19.8 ± 0.1 1.4 ± 0.1
Serum 17.6 ± 0.1 3.3 ± 0.2
Serum + SBA 17.4 ± 0.1 3.5 ± 0.2
(Gal)-PHEA35 and (Gal)-PHPMA40 GNRs in buffer, serum and serum
spiked with 100 µg mL−1 of SBA. Samples were incubated for 2 hours
in serum or serum spiked with SBA before performing the analysis (N
= 2, mean ± SD). Citrate-GNRs in Milli-Q water (peak size 22.3 ±
0.1 nm) were used as a “core-only” baseline in the core–shell model to
calculate the coating thickness.
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particles in complex biological matrices is a highly dynamic
process and that the rates of exchange are governed by the nano-
particle surface properties,53,72 supporting this hypothesis. The
different response of PHPMA GNRs can be attributable to its
lower grafting density (compared to PHEA) and hence more
vacancies on the GNR for formation of a ‘hard’ non-reversible
corona, supported by the DCS data. The PHPMA also has fewer
Gal residues and hence a likely decreased affinity for SBA may
also contribute. It should be noted that these experiments do
not rule out all SBA binding, just the lack of optical responses
or significant corona displacement.
To further explore the role of biocorona on the observed
sensing outputs bare citrate-GNRs, PHEA35 GNRs and Gal-
PHEA35 GNRs were incubated in human serum to allow corona
formation. After this, the rods were repeatedly washed with
buffer, to remove the most weakly bound coronal components.
This treatment leaves behind a “hard” corona composed of
biological molecules that have the highest affinity for the par-
ticle surface.53,73 Gal-PHEA35 GNRs prepared in this way
exhibited a pronounced blue-shift of the LSPR peak upon the
addition of 100 µg mL−1 SBA in buffer (Fig. 6), which was
larger than seen without washing, (Fig. 4) presumably due to
the absence of competing serum proteins in solution and
increased glycan accessibility. Nanoparticle tracking analysis
confirmed a decrease of the apparent particle size (Table 3 and
Fig. S17†) upon addition of SBA and hence supported the
hypothesis that SBA binding can displace some of the weaker
bond serum proteins upon glycan binding. Non-glycosylated
PHEA GNRs treated in the same manner showed no change in
particle size using NTA upon SBA addition confirming that the
displacement is due to specific lectin/glycan interactions. This
data also shows that the biocorona does not completely shield
the glycans on the GNR surface and that there is a dynamic
exchange between hard-corona proteins and SBA (see illus-
tration of proposed scheme in Fig. S18†). Moreover, the aspect
ratio of the GNRs (3.8) employed in this study corresponds to
the long GNRs (3.7) studied by Ferhan et al., which were
observed to show superior plasmonic surface sensitivity com-
pared to short GNR and long GNRs deposited on sensor
substrate.27
Fig. 5 SBA binding to Gal-PHEA GNRs in serum. Schematic illustration
of the formation of a biocorona surrounding Gal-PHEA coated GNR in a
complex biological environment. In serum spiked with SBA, we hypoth-
esise a displacement of the serum-derived biocorona due to glycan–
lectin binding.
Fig. 6 LSPR peak shift (nm) over time for citrate-GNRs, PHEA35 GNRs
and Gal-PHEA35 GNRs. The samples were incubated in serum to allow
the formation of a biocorona, followed by washing the rods with buffer.
Absorbance spectra were monitored for 1 hour in buffer, before spiking
(time zero) with SBA at 100 µg mL−1 (N = 3, mean ± SD).
Table 3 Nanoparticle tracking analysis particles in buffer and serum
Sample Medium Mode (nm)
Citrate-GNRs Water 43 ± 1.6
PHEA35 GNRs Buffer 54.5 ± 2.8
Serum, then buffer 98.5 ± 4.4
Serum, then buffer + SBA 100.8 ± 1.5
Gal-PHEA35 GNRs Buffer 52.6 ± 1.5
Serum, then buffer 106.1 ± 4.9
Serum, then buffer + SBA 61.3 ± 5.7
Glycopolymer-coated GNRs were analysed in buffer, after incubation in
serum followed by washing in buffer, and addition of 100 µg mL−1
SBA. The mode (nm) of a duplicate experiment (N = 2, mean ± SD) is
shown.
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Here we demonstrate how the nature of polymeric tethers,
used to anchor glycans to gold nanorods, directs the for-
mation of biocoronas in serum, and the impact this has on
biosensing of lectins. It is shown that prevention of biocor-
ona formation may not be essential, and that a soft-corona is
not only tolerated, but its displacement upon lectin binding
actually leads to signal generation. In contrast a ‘hard’ irre-
versible corona effectively prevented biosensing. In simple
buffer solutions, glycosylated poly(N-hydroxypropyl methacry-
lamide)-coated nanorods, showed a dose-dependent LSPR
red-shift upon addition of soybean agglutinin (SBA).
However, in serum, which contains a large range of biologi-
cal macromolecules, no signal was detected which is attribu-
ted to biocorona formation. In contrast, glycosylated poly(N-
hydroxyethyl acrylamide)-coated nanorods showed very
different behaviour including a lectin dose dependant blue-
shift in serum. Using a combination of UV-Visible spec-
troscopy, differential centrifugation sedimentation and nano-
particle tracking analysis the underlying mechanism for
these behaviours was proposed and harnessed to enable bio-
sensing of lectins in serum. Poly(N-hydroxypropyl methacryla-
mide)-coated nanorods were observed to have lower polymer
grafting densities, which upon incubation with serum led to
the formation of a thick and irreversibly bound ‘hard’
protein corona and hence no lectin binding was observable.
Changing the polymeric coating to poly(N-hydroxyethyl acryl-
amide) also resulted in biocorona formation in serum, but
this was a ‘soft’ corona containing irreversibly bound com-
ponents which could be displaced by addition of lectin. This
displacement mechanism leads to the blue-shifted lectin bio-
sensing outputs (overall loss of mass) in serum compared to
red-shifted (gain in mass) which is seen in buffer. The role
of grafting density in biocorona formation, and lectin
binding responses, was supported by the use of different
polymer chain-lengths on GNRs, with the shortest polymer
coatings (whilst still being long enough to provide colloidal
stability) giving the strongest responses, consistent with a
grafting-density dependant process. These results illustrate
how careful selection of the polymer coating on gold nano-
rods is an accessible and powerful tool to control observable
biosensing responses. It also shows that preventing all bio-
corona formation, which is incredibly challenging, on
plasmonic nanoparticle sensors may not be essential, so
long as the corona which does form is reversible and the
underlying targeting ligands remain exposed. Finally, this
work clearly shows that the polymer coating, not just the tar-
geting ligand, plays a critical role in tuning the biosensing
outputs and that the coating must be tuned for each appli-
cation area.
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